Sentences with phrase «neck cancer treatment»

Not exact matches

Immunotherapy doubles overall survival and improves quality of life, with fewer side effects, in a treatment - resistant and rapidly progressing form of head and neck carcinoma, reports a large, randomized international trial co-led by investigators at the University of Pittsburgh Cancer Institute (UPCI).

«These exciting results indicate that there is a new standard of care option for a population of head and neck cancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program atcancer patients with no other treatment options,» said the trial's international co-chair Robert Ferris, M.D., Ph.D., UPMC Endowed Professor, and chief of the Division of Head and Neck Surgery and co-leader of the Cancer Immunology Program atCancer Immunology Program at UPCI.

«Targeted drugs that are designed to inhibit any or all of these three steps might greatly improve the treatment of head and neck cancer.»

The findings provide information essential for designing novel targeted drugs that might improve the treatment of head and neck cancer.

Researchers at Oregon State University are pursuing a new concept in treatment of epithelial cancer, especially head and neck cancer, by using two promising «analogs» of an old compound that was once studied as a potent anti-tumor agent, but long ago abandoned because it was too toxic.

• Speech language pathologists work with many types of patients including those who have cochlear implantation surgery, suffer from a voice disorder or during rehabilitation following treatment for head and neck cancer.

Low saliva production also is a devastating problem for thousands of patients who have had radiation treatment for head and neck cancer, as well as about 50 percent of older Americans whose medications can cause dry mouth, also known as xerostomia.

«People with hepatitis C are two to five times more likely to develop certain head and neck cancers: first study to find association with new cancer types; findings have strong implications for screening and treatment.»

Reflux can be a common side effect of chemotherapy or radiation treatment for head and neck cancer.

They discovered that people with both head and neck squamous cell carcinoma and the KRAS - variant who were treated with standard treatment, but not with cetuximab, had a higher risk of failing treatment and developing metastatic disease, meaning the cancer spreads to distant organs and is incurable.

Between 32 % to 75 % of patients diagnosed with head and neck cancers cancer have surgery to remove the tumour as part of their primary cancer treatment.

Between 8 % and 61 % of patients diagnosed with head and neck cancers have chemotherapy as part of their primary cancer treatment.

Checkpoint inhibitors such as ipilimumab, nivolumab and pembrolizumab have had a dramatic impact on treatment of several tumor types, including melanoma, lung cancer, head and neck cancers and others.

City of Hope is a nationally recognized leader in the research and treatment of head and neck cancers.

If you have been diagnosed with a head and neck cancer, are at a high risk for developing this disease or are looking for a second opinion consultation about your treatment, you may request an appointment online or contact us at 800-826-4673 (HOPE).

Precise head and neck cancer tests are crucial for treatment planning, and City of Hope is equipped with state - of - the - art technologies and specialized staff to ensure an accurate, comprehensive diagnosis of head and neck cancer.

Head and neck cancers are particularly unique and complex, requiring a personalized treatment plan for optimal clinical, quality - of - life and cosmetic outcomes.

If you've been diagnosed with a head and neck cancer, talk to us about treatment options.

The drug or drug combination used depends on the type and stage of head and neck cancer, previous treatments used, the patient's health and overall treatment goals.

Radiation therapy is a lifesaver for patients with head and neck cancer, but the treatment takes a toll on the salivary gland.

The best treatment for head and neck cancers is guided by a team of specialists.

His research combines laboratory experiments and mathematical models to more fully understand how head and neck cancers form and how to better design treatments for these cancers.

Our multidisciplinary head and neck cancer team is nationally recognized for outstanding treatment outcomes.

This revolutionary, FDA - approved treatment has been successful in treating head - and - neck and prostate cancers.

Radiation therapy is a vital treatment for a wide range of cancers, from breast, lung and prostate cancers, to gastrointestinal and head and neck cancers.

Working with colleagues at the University of Chicago, our experts created a new combination chemotherapy and radiation therapy treatment regimen that helps some patients with advanced head and neck cancer avoid major surgery.

Head and neck cancer has one currently approved immunotherapy, the checkpoint inhibitor nivolumab (Opdivo ®) and is one of the major cancer types for which new immune - based cancer treatments are in development.

This page features information on head and neck cancer and immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer and immunotherapy clinical trials for head and neck cancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer patients, and highlights the Cancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patCancer Research Institute's role in working to bring effective immune - based cancer treatments to head and neck cancer patcancer treatments to head and neck cancer patcancer patients.

Summary: Intensive treatment combining radiation and chemotherapy can control locally advanced head and neck cancer, improve survival and in most cases eliminate the need for debilitating surgery.

Intensive treatment combining radiation and chemotherapy can control locally advanced head and neck cancer, improve survival, and in most cases eliminate the need for debilitating surgery, report researchers from the University of Chicago Medical Center and Northwestern University in the April 14, 2000, issue of the Journal of Clinical Oncology.

April 13, 2000 Combined therapy improves survival for advanced head and neck cancer Intensive treatment combining radiation and chemotherapy can control locally advanced head and neck cancer, improve survival and in most cases eliminate the need for debilitating surgery.

During the study, the researchers tracked the pre-and-post treatment diets and ultimate health outcomes of more than 400 cancer patients for an average of 26 months after they were first diagnosed and treated for squamous - cell carcinoma of the head or neck.

Located a few blocks away from the main facility, Rutgers Cancer Institute's Programs at Plum Street provide advanced treatment options for malignant as well as benign disorders of the head, neck, brain and spine.

Researchers from the University of Illinois at Urbana - Champaign have found that consuming higher amounts of carbohydrates and various forms of sugar a year prior to treatment for head or neck cancer could increase risk of cancer recurrence and mortality.

Paclitaxel (Taxol ®) is a widely - used anticancer agent for treatment of ovarian, breast, lung, head, and neck cancer with two serious side effects: myelosuppression and peripheral sensory neurotoxicity which limits its use in high / cumulative doses or in combination with other anticancer agents.

The Program specializes in the treatment of primary head and neck cancers, brain and spine tumors such as squamous cell carcinoma, basal cell cancer, glomus tumor, paragangliomas, acoustic neuromas, salivary gland and mucosal tumors, astrocytomas, oligodendrogliomas, glioblastomas, and hemangioblastomas, and metastatic tumors that may have arisen from elsewhere in the body such as the breast, lung, or prostate.

Tags: cancer genomics, Carla Grandori, Christopher J Kemp, Clinical Research, Eddie Mendez, Good News, head neck cancers, Human Biology, Jerald P Radich, personalized treatment, precision medicine, Tumor specific translational research, Vijayakrishna Gadi

Her current focus is on developing clinical protocols for the treatment of head and neck and lung cancers with a goal of providing enhanced tumor control, including control of metastases, with minimal effect of quality of life.

Conventional medicine's main types of treatment for head and neck cancers include: • Surgery • Radiation therapy • Chemotherapy • Targeted therapy • Palliative therapy

The next are medical treatments for hyperthyroidism (designed to slow the thyroid), radiation treatment for cancers of the head and neck, thyroid surgery (removal of some or all of the gland), or side effects of drugs for other conditions.

People who have had x-ray treatment for cancers of the head and neck may develop hypothyroidism if their thyroid was exposed to radiation during the cancer treatment.

Other causes include trauma to the neck head or chest from a car accident or bite wound, disease to the eye's orbit, middle ear infection, disc disease in the neck, brain or chest cancer or the result of treatment such as ear cleaning or medication.

ENTA has a clinical alliance with The Mount Sinai Hospital for the treatment of diseases of the head and neck and esophageal cancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and ccancer and a partnership with the American Cancer Society to educate and treat patients with smoking disorders and cCancer Society to educate and treat patients with smoking disorders and cancercancer.

Among the Center's affiliations have been those with North General Hospital, serving low income families with diabetes, asthma, chronic pain, cancer and HIV / AIDS; The Family Center, working with families coping with the loss of a parent to cancer or HIV / AIDS; Maimonides Hospital, dealing with couples in which one spouse has cardiac illness; Memorial Sloan - Kettering Cancer Center, offering services to families with head and neck cancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diacancer and HIV / AIDS; The Family Center, working with families coping with the loss of a parent to cancer or HIV / AIDS; Maimonides Hospital, dealing with couples in which one spouse has cardiac illness; Memorial Sloan - Kettering Cancer Center, offering services to families with head and neck cancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diacancer or HIV / AIDS; Maimonides Hospital, dealing with couples in which one spouse has cardiac illness; Memorial Sloan - Kettering Cancer Center, offering services to families with head and neck cancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 DiaCancer Center, offering services to families with head and neck cancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diacancer and families with adolescents who are post-cancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diacancer treatment; and the Naomi Berrie Diabetes Center, Columbia - Presbyterian Hospital Center, offering Multiple Family Discussion Group for families with one or more members with either Type 1 or Type 2 Diabetes.